Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Erasca, Inc.

ERASNASDAQ
Healthcare
Biotechnology
$13.62
$-1.03(-7.03%)
U.S. Market opens in 14h 39m

Erasca, Inc. (ERAS) Stock Overview

Explore Erasca, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio-31.68
EPS (TTM)$-0.43
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$14.65
3 Months$19.37
1 Year Target$6.85

ERAS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Erasca, Inc. (ERAS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.68 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.03%
5-Day Change
-12.58%
1-Month Change
13.50%
3-Month Change
278.33%
6-Month Change
773.08%
Year-to-Date (YTD) Change
279.39%
1-Year Change
826.53%
3-Year Change
324.30%
5-Year Change
-21.86%
All-Time (Max) Change
-21.86%

Contact Information

858 465 6511
10835 Road to the Cure, San Diego, CA, 92121

Company Facts

1,030 Employees
IPO DateJul 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions